GSK Plc CEO Emma Walmsley doesn’t want the company’s employees spending any time thinking about the ongoing litigation over ...
The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...
In this month's trial, which began on Aug. 28, Eric Olson ( Olson Grimsley) and Ashley Keller ( Keller Postman) represented ...
The brand of this medicine does not contain ranitidine, a medicine that was ... medicine if you are pregnant or breastfeeding. Some side effects may be more likely in older adults and in people ...
Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...
A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported.
However, they differ in how they work, their duration of use, and their side effects. Famotidine treats gastroesophageal ...
Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine. On 13 September, both the US Food and Drug ...
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. When the FDA issued a bulletin alerting everyone to the presence of a possible cancer ...
(Reuters) - British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any ...
Delaware Top Court Will Hear Drugmakers' Appeal to End Zantac Lawsuits By Brendan Pierson (Reuters) - Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers ...
Aug 27 (Reuters) - Delaware's highest court said on Tuesday it will hear an appeal by GSK (GSK.L), opens new tab and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued ...